Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Long noncoding RNA DLEU2 regulates the progression of Wilm's tumor via miR-539-3p/HOXB2 axis.J Pediatr Urol. 2022; (In press)
- Noncoding RNA therapeutics – challenges and potential solutions.Nat Rev Drug Discov. 2021; 20: 629-651
- From clinical trials to clinical practice: practical considerations for gene replacement therapy in SMA Type 1.Pediatr Neurol. 2019; 100: 3-11
- Lumasiran: first approval.Drugs. 2021; 81: 277-282